Ir al contenido principal

16° SEMINARIO QUÍMICA ORGÁNICA IQUIR 2024

SEMINARIO QUÍMICA ORGÁNICA 2-9-24

EXPOSITOR: Lic. Renzo Carlucci

TÍTULO: "The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods"

FUENTE:  Barbara Zdrazil et al. Nucleic Acids Research, Volume 52, Issue D1, 5 January 2024, Pages D1180–D1192, https://doi.org/10.1093/nar/gkad1004

DÍA, HORA y LUGAR: Lunes 2 de septiembre de 2024, 14:00 h, Aula 18 y virtual.

Modalidad virtual, Linkmeet.google.com/hjn-ygro-twf (Plataforma MEET GOOGLE)

ResumenChEMBL (https://www.ebi.ac.uk/chembl/) is a manually curated, high-quality, large-scale, open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like properties, previously described in the 2012, 2014, 2017 and 2019 Nucleic Acids Research Database Issues. Since its introduction in 2009, ChEMBL’s content has changed dramatically in size and diversity of data types. Through incorporation of multiple new datasets from depositors since the 2019 update, ChEMBL now contains slightly more bioactivity data from deposited data vs data extracted from literature. In collaboration with the EUbOPEN consortium, chemical probe data is now regularly deposited into ChEMBL. Release 27 made curated data available for compounds screened for potential anti-SARS-CoV-2 activity from several large-scale drug repurposing screens. In addition, new patent bioactivity data have been added to the latest ChEMBL releases, and various new features have been incorporated, including a Natural Product likeness score, updated flags for Natural Products, a new flag for Chemical Probes, and the initial annotation of the action type for ∼270 000 bioactivity measurements.


Comentarios

Entradas populares de este blog

24° SEMINARIO QUÍMICA ORGÁNICA IQUIR 2024

SEMINARIO QUÍMICA ORGÁNICA 11-11-24 EXPOSITOR :  Qca. Paula Paz Armero TÍTULO :  " Total synthesis of (±)‐decursivine via BINOL‐phosphoric acid catalyzed tandem oxidative cyclization ". FUENTE : PrakashT. Parvatkar, Eugene S. Smotkin & Roman Manetsc,  Scientific Reports volume 11, Article number: 19915 (2021) DÍA, HORA y LUGAR : Lunes 11 de noviembre de 2024, 14:00 h, Aula 18 y virtual. Modalidad virtual, Link :  meet.google.com/hjn-ygro-twf  ( Plataforma MEET GOOGLE) Resumen : The synthesis of tetracyclic indole alkaloid (±)-decursivine was accomplished using BINOL-phosphoric acid catalyzed tandem oxidative cyclization as a key step with (bis(trifuoroacetoxy)iodo)benzene (PIFA) as an oxidizing agent. This represents one of the shortest and highest yielding routes for the synthesis of (±)-decursivine from readily available starting materials.

18° SEMINARIO QUÍMICA ORGÁNICA IQUIR 2024

SEMINARIO QUÍMICA ORGÁNICA 16-9-24 EXPOSITOR :  Dr. Enrique L. Larghi TÍTULO :   " Total Synthesis of Isoxeniolide A " FUENTE :     Leo Betschart and Karl-Heinz Altmann. Angew. Chem. Int. Ed. 2024, 63, e202315423, DOI: 10.1002/anie.202315423. DÍA, HORA y LUGAR : Lunes 16 de septiembre de 2024, 14:00 h, Aula 18 y virtual. Modalidad virtual, Link :  meet.google.com/hjn-ygro-twf  ( Plataforma MEET GOOGLE) Resumen : The total synthesis of the xenicane-type marine natural product isoxeniolide A has been accomplished through a ring-opening/ring-closing metathesis sequence and an intramolecular Nozaki–Hiyama–Kishi (NHK) reaction to forge the nine-membered ring as the key enabling steps. The NHK cyclization was highly diastereoselective and provided the oxabicyclo[7.4.0]tridecene core of isoxeniolide A as a single stereoisomer.

10° SEMINARIO QUÍMICA ORGÁNICA IQUIR 2024

SEMINARIO QUÍMICA ORGÁNICA 24-6-24 EXPOSITOR :  Qco. Miguel Villarreal Parra TÍTULO :   " Nitro-Group-Containing Drugs " FUENTE :   DOI: https://doi.org/10.1021/acs.jmedchem.8b00147 Kunal Nepali, Hsueh-Yun Lee, and Jing-Ping Liou* J. Med. Chem. 2019, 62, 6, 2851–2893. DÍA, HORA y LUGAR : Lunes 24 de junio de 2024, 14:00 h, Aula 18 y virtual. Modalidad virtual, Link :  meet.google.com/hjn-ygro-twf  ( Plataforma MEET GOOGLE) Resumen :  The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts toward the structure–mutagenicity or structure–genotoxicity relationsh...